接受高压氧辅助治疗的钙过敏症患者的治疗结果和与康复相关的因素

Norman McCulloch MD , Susan M. Wojcik PhD , Marvin Heyboer III MD
{"title":"接受高压氧辅助治疗的钙过敏症患者的治疗结果和与康复相关的因素","authors":"Norman McCulloch MD ,&nbsp;Susan M. Wojcik PhD ,&nbsp;Marvin Heyboer III MD","doi":"10.1016/j.jccw.2016.08.004","DOIUrl":null,"url":null,"abstract":"<div><p><span><span>Calcific uremic arteriolopathy, also known as calciphylaxis, is a rare syndrome of small vessel calcification of unknown etiology causing painful, violaceous </span>skin lesions<span><span> that progress to form chronic non-healing ulcers<span> and gangrene. Hyperbaric oxygen therapy (HBOT) can be used as adjunctive therapy in the </span></span>treatment of these ulcers. However, due to paucity of cases, there is limited data on the clinical benefit of HBOT and identifying factors associated with healing. The purpose of this study was to determine patient outcomes and factors associated with healing </span></span>in patients<span><span><span> with calciphylaxis undergoing HBOT. A retrospective chart review was completed on patients who were diagnosed with calciphylaxis and had hyperbaric medicine consultation between May 2012 and January 2016. Clinical outcomes, demographics, risk factors, laboratory values, wound distribution, and HBOT profiles were collected and analyzed. We identified 8 patients. Out of 8 patients consulted for calciphylaxis, five were consented and underwent HBOT (2 males and 3 females). All had coexisting ESRD and Diabetes. All males were able to tolerate being in the chamber and received therapeutic treatments (at least 20 HBOT) with complete resolution of ulcers. HBOT was discontinued in one female due to an inconsistent biopsy report and two others due to death secondary to </span>septic shock or respiratory arrest and severe </span>uremia. Calciphylaxis is a devastating disease with a high mortality rate. Our results demonstrated a positive response to HBOT especially when receiving at least 20 treatments. A majority of calciphylaxis cases are females and indeed female gender has been cited as a risk factor for this disease. However, current literature has not conferred a relationship between gender nor the number of HBOT received and outcomes. Our results showed that males had a more favorable outcome provided they received at least twenty HBOT. Further prospective studies are needed to elucidate these outcomes.</span></p></div>","PeriodicalId":90358,"journal":{"name":"The journal of the American College of Clinical Wound Specialists","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2015-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jccw.2016.08.004","citationCount":"8","resultStr":"{\"title\":\"Patient Outcomes and Factors Associated with Healing in Calciphylaxis Patients Undergoing Adjunctive Hyperbaric Oxygen Therapy\",\"authors\":\"Norman McCulloch MD ,&nbsp;Susan M. Wojcik PhD ,&nbsp;Marvin Heyboer III MD\",\"doi\":\"10.1016/j.jccw.2016.08.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span><span>Calcific uremic arteriolopathy, also known as calciphylaxis, is a rare syndrome of small vessel calcification of unknown etiology causing painful, violaceous </span>skin lesions<span><span> that progress to form chronic non-healing ulcers<span> and gangrene. Hyperbaric oxygen therapy (HBOT) can be used as adjunctive therapy in the </span></span>treatment of these ulcers. However, due to paucity of cases, there is limited data on the clinical benefit of HBOT and identifying factors associated with healing. The purpose of this study was to determine patient outcomes and factors associated with healing </span></span>in patients<span><span><span> with calciphylaxis undergoing HBOT. A retrospective chart review was completed on patients who were diagnosed with calciphylaxis and had hyperbaric medicine consultation between May 2012 and January 2016. Clinical outcomes, demographics, risk factors, laboratory values, wound distribution, and HBOT profiles were collected and analyzed. We identified 8 patients. Out of 8 patients consulted for calciphylaxis, five were consented and underwent HBOT (2 males and 3 females). All had coexisting ESRD and Diabetes. All males were able to tolerate being in the chamber and received therapeutic treatments (at least 20 HBOT) with complete resolution of ulcers. HBOT was discontinued in one female due to an inconsistent biopsy report and two others due to death secondary to </span>septic shock or respiratory arrest and severe </span>uremia. Calciphylaxis is a devastating disease with a high mortality rate. Our results demonstrated a positive response to HBOT especially when receiving at least 20 treatments. A majority of calciphylaxis cases are females and indeed female gender has been cited as a risk factor for this disease. However, current literature has not conferred a relationship between gender nor the number of HBOT received and outcomes. Our results showed that males had a more favorable outcome provided they received at least twenty HBOT. Further prospective studies are needed to elucidate these outcomes.</span></p></div>\",\"PeriodicalId\":90358,\"journal\":{\"name\":\"The journal of the American College of Clinical Wound Specialists\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.jccw.2016.08.004\",\"citationCount\":\"8\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The journal of the American College of Clinical Wound Specialists\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2213510316300355\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The journal of the American College of Clinical Wound Specialists","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213510316300355","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8

摘要

钙化性尿毒症动脉病变,也被称为钙化反应,是一种罕见的病因不明的小血管钙化综合征,会导致疼痛的紫色皮肤病变,进而形成慢性不愈合的溃疡和坏疽。高压氧治疗(HBOT)可作为辅助治疗这些溃疡。然而,由于病例稀少,关于HBOT的临床益处和确定与愈合相关的因素的数据有限。本研究的目的是确定接受HBOT治疗的钙过敏症患者的治疗结果和与愈合相关的因素。对2012年5月至2016年1月期间被诊断为钙过敏症并接受高压医学咨询的患者进行了回顾性图表审查。收集并分析临床结果、人口统计学、危险因素、实验室值、伤口分布和HBOT档案。我们确定了8名患者。在8名接受钙过敏症咨询的患者中,有5名患者同意并接受了HBOT(2名男性和3名女性)。所有患者同时患有ESRD和糖尿病。所有男性都能耐受在室内,并接受治疗(至少20次HBOT),溃疡完全消退。一名女性因活检报告不一致而停止HBOT,另外两名女性因感染性休克或呼吸停止和严重尿毒症继发死亡而停止。钙过敏症是一种死亡率很高的破坏性疾病。我们的研究结果表明,对HBOT有积极反应,尤其是在接受至少20次治疗时。大多数钙过敏症病例是女性,事实上,女性被认为是这种疾病的危险因素。然而,目前的文献并没有给出性别之间的关系,也没有给出接受HBOT的数量和结果之间的关系。我们的研究结果表明,如果男性接受了至少20次HBOT,他们的结果会更有利。需要进一步的前瞻性研究来阐明这些结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Patient Outcomes and Factors Associated with Healing in Calciphylaxis Patients Undergoing Adjunctive Hyperbaric Oxygen Therapy

Calcific uremic arteriolopathy, also known as calciphylaxis, is a rare syndrome of small vessel calcification of unknown etiology causing painful, violaceous skin lesions that progress to form chronic non-healing ulcers and gangrene. Hyperbaric oxygen therapy (HBOT) can be used as adjunctive therapy in the treatment of these ulcers. However, due to paucity of cases, there is limited data on the clinical benefit of HBOT and identifying factors associated with healing. The purpose of this study was to determine patient outcomes and factors associated with healing in patients with calciphylaxis undergoing HBOT. A retrospective chart review was completed on patients who were diagnosed with calciphylaxis and had hyperbaric medicine consultation between May 2012 and January 2016. Clinical outcomes, demographics, risk factors, laboratory values, wound distribution, and HBOT profiles were collected and analyzed. We identified 8 patients. Out of 8 patients consulted for calciphylaxis, five were consented and underwent HBOT (2 males and 3 females). All had coexisting ESRD and Diabetes. All males were able to tolerate being in the chamber and received therapeutic treatments (at least 20 HBOT) with complete resolution of ulcers. HBOT was discontinued in one female due to an inconsistent biopsy report and two others due to death secondary to septic shock or respiratory arrest and severe uremia. Calciphylaxis is a devastating disease with a high mortality rate. Our results demonstrated a positive response to HBOT especially when receiving at least 20 treatments. A majority of calciphylaxis cases are females and indeed female gender has been cited as a risk factor for this disease. However, current literature has not conferred a relationship between gender nor the number of HBOT received and outcomes. Our results showed that males had a more favorable outcome provided they received at least twenty HBOT. Further prospective studies are needed to elucidate these outcomes.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Is Treating all Pressure Wound Patients with Vitamins A, C, Zinc and Arginine Justified?∗ Omegaven Improves Skin Morphometric Indices in Diabetic Rat Model Wound Healing Managing Wounds with Exposed Bone and Tendon with an Esterified Hyaluronic Acid Matrix (eHAM): A Literature Review and Personal Experience Breast Cerclage: An Innovative Expedient for Perimammary Dehiscence Healing Skin Perfusion Pressure and Wound Closure Time in Lower Extremity Wounds
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1